Raising the Alarm: ‘Who Can Report?’
Unveiling the Power of Yellow Card Reporting in #MedSafetyWeek 2023

November 6th marks the start of the eighth annual MedSafetyWeek. This year’s campaign led by the Medicines and Healthcare Products Regulatory Agency (MHRA), is all about the power of reporting. By simply filling out a Yellow Card report, you can contribute to improving healthcare product safety and protecting patients worldwide.

What’s MedSafetyWeek All About?

MedSafetyWeek is a global initiative aimed at raising awareness about the vital role of reporting suspected adverse reactions to national medicines regulatory authorities. In 2023, over 80 countries are joining forces under the theme ‘Who can report?’- emphasising that everyone, from patients and caregivers to healthcare professionals, all reporters play a crucial role in enhancing patient safety.

Your Role: Report, Share, and Educate

Here’s what you can do to support MedSafetyWeek:

  1. Report Promptly: Don’t hesitate – report any suspected adverse reactions or issues with medicines, medical devices, e-cigarettes and their refills, herbal or homeopathic medicines and low-quality or falsified healthcare products to the Yellow Card scheme. Even a suspicion is enough to make a difference. You can use the Yellow Card app, available on both the Apple App Store and Google Play Store.
  2. Spread the Word: Utilise social media to raise awareness. Follow the MHRA’s social media channels and share, retweet, comment, and like using hashtags #MHRAYellowCard, #MedSafetyWeek, #ReportSideEffects, and #PatientSafety. Your reach could save lives. Speak to your colleagues about being vigilant for suspected adverse reactions.
  3. Stay Vigilant: Stay alert for suspected adverse reactions, especially new, serious, rare, or delayed-onset reactions.

Wondering how your report can make a difference?

High quality adverse event reporting is a cornerstone of effective Pharmacovigilance. By reporting to the Yellow Card scheme, you help the MHRA monitor the safety of healthcare products post-market. Your input enables the identification of new adverse effects and contributes significantly to our understanding and monitoring of changes to the risk-benefit profiles of these medicines.

Did you know?

A medicines safety profile and efficacy can differ in different populations – by including patient characteristics and special situation information such as use during pregnancy or off label use, you help Regulatory Authorities take appropriate actions to minimise risk and maximise benefit. Together, we contribute to the safe use of healthcare products, ensuring the well-being of patients around the world.

Access Resources and Support

The Yellow Card website offers valuable information and resources, accredited e-learning modules, and promotional materials.

For support with Pharmacovigilance, including the Yellow Card scheme, or support with ongoing projects, contact our Pharmacovigilance Team Leader Oscar Carter-Burns at oscar.carterburns@jensongroup.com or our general enquiry contact business.development@jensongroup.com.
Lauren Foster
Latest posts by Lauren Foster (see all)